Nakamura and colleagues revealed that patients in the CAD group without T2DM than in the Non-CAD group have higher significant levels of postprandial plasma insulin and dyslipidemia and raised this biomarker might play a critical role in the progress of atherosclerosis even before diabetes occurrence [6]. The gene discussed is INS; the disease is metabolic syndrome.